ArticleAntimicrobial agents and chemotherapy2005
Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum.
Article in Antimicrobial agents and chemotherapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 26 citations in OpenAlex.
- Nitric Oxide Resistance inAntioxidants (Basel, Switzerland) · 2022Article
- Leishmanicidal Activity of Betulin Derivatives inMicroorganisms · 2021Article
- Leishmania infantum induces high phagocytic capacity and intracellular nitric oxide production by human proinflammatory monocyte.Memorias do Instituto Oswaldo Cruz · 2020Article
- Resistance ofFrontiers in immunology · 2018Article
- Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.Parasitology research · 2016Article
- Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence.PLoS neglected tropical diseases · 2014Article
- Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony.Parasitology research · 2014Article
- Antimony resistance and environment: Elusive links to explore during Leishmania life cycle.International journal for parasitology. Drugs and drug resistance · 2012Article
- Leishmania antimony resistance: what we know what we can learn from the field.Parasitology research · 2011Review
- Article
- Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.BMC infectious diseases · 2010Article
- Canine leishmaniasis in Southern Italy: a role for nitric oxide released from activated macrophages in asymptomatic infection?Parasites & vectors · 2008Article
- Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes.Antimicrobial agents and chemotherapy · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We previously documented the induction of Leishmania amastigote apoptosis by trivalent antimony (SbIII) and nitric oxide (NO). We demonstrate here that SbIII-resistant amastigotes were resistant to NO toxicity when delivered extracellularly by NO donors or intracellularly via macrophage activation. Shared biochemical targets for SbIII and NO resistance in Leishmania are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.